Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

J. Beyer; P. Albers; R. Altena; J. Aparicio; C. Bokemeyer; J. Busch; R. Cathomas; Eva Cavallin-Ståhl; N. W. Clarke; J. Classen; G. Cohn-Cedermark; A. A. Dahl; G. Daugaard; U. De Giorgi; M. De Santis; M. De Wit; R. De Wit; K. P. Dieckmann; M. Fenner; K. Fizazi; A. Flechon; S. D. Fossa; J. R. Germa Lluch; J. A. Gietema; S. Gillessen; Aleksander Giwercman; J. T. Hartmann; A. Heidenreich; M. Hentrich; F. Honecker; A. Horwich; R. A. Huddart; S. Kliesch; C. Kollmannsberger; S. Krege; M. P. Laguna; L. H. J. Looijenga; A. Lorch; J. P. Lotz; F. Mayer; A. Necchi; N. Nicolai; J. Nuver; K. Oechsle; J. Oldenburg; J. W. Oosterhuis; T. Powles; E. Rajpert-De Meyts; O. Rick; G. Rosti; R. Salvioni; M. Schrader; S. Schweyer; F. Sedlmayer; A. Sohaib; R. Souchon; T. Tandstad; C. Winter; C. Wittekind

doi:10.1093/annonc/mds579

Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

J. Beyer, P. Albers, R. Altena, J. Aparicio, C. Bokemeyer, J. Busch, R. Cathomas, Eva Cavallin-Ståhl, N. W. Clarke, J. Classen, G. Cohn-Cedermark, A. A. Dahl, G. Daugaard, U. De Giorgi, M. De Santis, M. De Wit, R. De Wit, K. P. Dieckmann, M. Fenner, K. FizaziA. Flechon, S. D. Fossa, J. R. Germa Lluch, J. A. Gietema, S. Gillessen, Aleksander Giwercman, J. T. Hartmann, A. Heidenreich, M. Hentrich, F. Honecker, A. Horwich, R. A. Huddart, S. Kliesch, C. Kollmannsberger, S. Krege, M. P. Laguna, L. H. J. Looijenga, A. Lorch, J. P. Lotz, F. Mayer, A. Necchi, N. Nicolai, J. Nuver, K. Oechsle, J. Oldenburg, J. W. Oosterhuis, T. Powles, E. Rajpert-De Meyts, O. Rick, G. Rosti, R. Salvioni, M. Schrader, S. Schweyer, F. Sedlmayer, A. Sohaib, R. Souchon, T. Tandstad, C. Winter, C. Wittekind

Forskningsoutput: Tidskriftsbidrag › Översiktsartikel › Peer review

Sammanfattning

In November 2011, the Third European Consensus Conference on Diagnosis and Treatment of Germ-Cell Cancer (GCC) was held in Berlin, Germany. This third conference followed similar meetings in 2003 (Essen, Germany) and 2006 (Amsterdam, The Netherlands) [Schmoll H-J, Souchon R, Krege S et al. European consensus on diagnosis and treatment of germ-cell cancer: a report of the European Germ-Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004; 15: 1377-1399; Krege S, Beyer J, Souchon R et al. European consensus conference on diagnosis and treatment of germ-cell cancer: a report of the second meeting of the European Germ-Cell Cancer Consensus group (EGCCCG): part I. Eur Urol 2008; 53: 478-496; Krege S, Beyer J, Souchon R et al. European consensus conference on diagnosis and treatment of germ-cell cancer: a report of the second meeting of the European Germ-Cell Cancer Consensus group (EGCCCG): part II. Eur Urol 2008; 53: 497-513]. A panel of 56 of 60 invited GCC experts from all across Europe discussed all aspects on diagnosis and treatment of GCC, with a particular focus on acute and late toxic effects as well as on survivorship issues. The panel consisted of oncologists, urologic surgeons, radiooncologists, pathologists and basic scientists, who are all actively involved in care of GCC patients. Panelists were chosen based on the publication activity in recent years. Before the meeting, panelists were asked to review the literature published since 2006 in 20 major areas concerning all aspects of diagnosis, treatment and follow-up of GCC patients, and to prepare an updated version of the previous recommendations to be discussed at the conference. In addition, similar to 50 E-vote questions were drafted and presented at the conference to address the most controversial areas for a poll of expert opinions. Here, we present the main recommendations and controversies of this meeting. The votes of the panelists are added as online supplements.

Originalspråk	engelska
Sidor (från-till)	878-888
Tidskrift	Annals of Oncology
Volym	24
Nummer	4
DOI	https://doi.org/10.1093/annonc/mds579
Status	Published - 2013

Ämnesklassifikation (UKÄ)

Cancer och onkologi

FN:s Globala mål

Denna forskningsoutput relaterar till följande Globala mål

Tillgång till dokument

10.1093/annonc/mds579

Citera det här

Beyer, J., Albers, P., Altena, R., Aparicio, J., Bokemeyer, C., Busch, J., Cathomas, R., Cavallin-Ståhl, E., Clarke, N. W., Classen, J., Cohn-Cedermark, G., Dahl, A. A., Daugaard, G., De Giorgi, U., De Santis, M., De Wit, M., De Wit, R., Dieckmann, K. P., Fenner, M., ... Wittekind, C. (2013). Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Annals of Oncology, 24(4), 878-888. https://doi.org/10.1093/annonc/mds579

@article{0da22759f4ef4a6cbc90571540ede61f,

title = "Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer",

abstract = "In November 2011, the Third European Consensus Conference on Diagnosis and Treatment of Germ-Cell Cancer (GCC) was held in Berlin, Germany. This third conference followed similar meetings in 2003 (Essen, Germany) and 2006 (Amsterdam, The Netherlands) [Schmoll H-J, Souchon R, Krege S et al. European consensus on diagnosis and treatment of germ-cell cancer: a report of the European Germ-Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004; 15: 1377-1399; Krege S, Beyer J, Souchon R et al. European consensus conference on diagnosis and treatment of germ-cell cancer: a report of the second meeting of the European Germ-Cell Cancer Consensus group (EGCCCG): part I. Eur Urol 2008; 53: 478-496; Krege S, Beyer J, Souchon R et al. European consensus conference on diagnosis and treatment of germ-cell cancer: a report of the second meeting of the European Germ-Cell Cancer Consensus group (EGCCCG): part II. Eur Urol 2008; 53: 497-513]. A panel of 56 of 60 invited GCC experts from all across Europe discussed all aspects on diagnosis and treatment of GCC, with a particular focus on acute and late toxic effects as well as on survivorship issues. The panel consisted of oncologists, urologic surgeons, radiooncologists, pathologists and basic scientists, who are all actively involved in care of GCC patients. Panelists were chosen based on the publication activity in recent years. Before the meeting, panelists were asked to review the literature published since 2006 in 20 major areas concerning all aspects of diagnosis, treatment and follow-up of GCC patients, and to prepare an updated version of the previous recommendations to be discussed at the conference. In addition, similar to 50 E-vote questions were drafted and presented at the conference to address the most controversial areas for a poll of expert opinions. Here, we present the main recommendations and controversies of this meeting. The votes of the panelists are added as online supplements.",

keywords = "consensus conference, diagnosis, germ-cell cancer, late toxic effects, long-term follow-up, treatment",

author = "J. Beyer and P. Albers and R. Altena and J. Aparicio and C. Bokemeyer and J. Busch and R. Cathomas and Eva Cavallin-St{\aa}hl and Clarke, {N. W.} and J. Classen and G. Cohn-Cedermark and Dahl, {A. A.} and G. Daugaard and {De Giorgi}, U. and {De Santis}, M. and {De Wit}, M. and {De Wit}, R. and Dieckmann, {K. P.} and M. Fenner and K. Fizazi and A. Flechon and Fossa, {S. D.} and {Germa Lluch}, {J. R.} and Gietema, {J. A.} and S. Gillessen and Aleksander Giwercman and Hartmann, {J. T.} and A. Heidenreich and M. Hentrich and F. Honecker and A. Horwich and Huddart, {R. A.} and S. Kliesch and C. Kollmannsberger and S. Krege and Laguna, {M. P.} and Looijenga, {L. H. J.} and A. Lorch and Lotz, {J. P.} and F. Mayer and A. Necchi and N. Nicolai and J. Nuver and K. Oechsle and J. Oldenburg and Oosterhuis, {J. W.} and T. Powles and {Rajpert-De Meyts}, E. and O. Rick and G. Rosti and R. Salvioni and M. Schrader and S. Schweyer and F. Sedlmayer and A. Sohaib and R. Souchon and T. Tandstad and C. Winter and C. Wittekind",

year = "2013",

doi = "10.1093/annonc/mds579",

language = "English",

volume = "24",

pages = "878--888",

journal = "Annals of Oncology",

issn = "1569-8041",

publisher = "Oxford University Press",

number = "4",

}

Beyer, J, Albers, P, Altena, R, Aparicio, J, Bokemeyer, C, Busch, J, Cathomas, R, Cavallin-Ståhl, E, Clarke, NW, Classen, J, Cohn-Cedermark, G, Dahl, AA, Daugaard, G, De Giorgi, U, De Santis, M, De Wit, M, De Wit, R, Dieckmann, KP, Fenner, M, Fizazi, K, Flechon, A, Fossa, SD, Germa Lluch, JR, Gietema, JA, Gillessen, S, Giwercman, A, Hartmann, JT, Heidenreich, A, Hentrich, M, Honecker, F, Horwich, A, Huddart, RA, Kliesch, S, Kollmannsberger, C, Krege, S, Laguna, MP, Looijenga, LHJ, Lorch, A, Lotz, JP, Mayer, F, Necchi, A, Nicolai, N, Nuver, J, Oechsle, K, Oldenburg, J, Oosterhuis, JW, Powles, T, Rajpert-De Meyts, E, Rick, O, Rosti, G, Salvioni, R, Schrader, M, Schweyer, S, Sedlmayer, F, Sohaib, A, Souchon, R, Tandstad, T, Winter, C & Wittekind, C 2013, 'Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer', Annals of Oncology, vol. 24, nr. 4, s. 878-888. https://doi.org/10.1093/annonc/mds579

TY - JOUR

T1 - Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

AU - Beyer, J.

AU - Albers, P.

AU - Altena, R.

AU - Aparicio, J.

AU - Bokemeyer, C.

AU - Busch, J.

AU - Cathomas, R.

AU - Cavallin-Ståhl, Eva

AU - Clarke, N. W.

AU - Classen, J.

AU - Cohn-Cedermark, G.

AU - Dahl, A. A.

AU - Daugaard, G.

AU - De Giorgi, U.

AU - De Santis, M.

AU - De Wit, M.

AU - De Wit, R.

AU - Dieckmann, K. P.

AU - Fenner, M.

AU - Fizazi, K.

AU - Flechon, A.

AU - Fossa, S. D.

AU - Germa Lluch, J. R.

AU - Gietema, J. A.

AU - Gillessen, S.

AU - Giwercman, Aleksander

AU - Hartmann, J. T.

AU - Heidenreich, A.

AU - Hentrich, M.

AU - Honecker, F.

AU - Horwich, A.

AU - Huddart, R. A.

AU - Kliesch, S.

AU - Kollmannsberger, C.

AU - Krege, S.

AU - Laguna, M. P.

AU - Looijenga, L. H. J.

AU - Lorch, A.

AU - Lotz, J. P.

AU - Mayer, F.

AU - Necchi, A.

AU - Nicolai, N.

AU - Nuver, J.

AU - Oechsle, K.

AU - Oldenburg, J.

AU - Oosterhuis, J. W.

AU - Powles, T.

AU - Rajpert-De Meyts, E.

AU - Rick, O.

AU - Rosti, G.

AU - Salvioni, R.

AU - Schrader, M.

AU - Schweyer, S.

AU - Sedlmayer, F.

AU - Sohaib, A.

AU - Souchon, R.

AU - Tandstad, T.

AU - Winter, C.

AU - Wittekind, C.

PY - 2013

Y1 - 2013

N2 - In November 2011, the Third European Consensus Conference on Diagnosis and Treatment of Germ-Cell Cancer (GCC) was held in Berlin, Germany. This third conference followed similar meetings in 2003 (Essen, Germany) and 2006 (Amsterdam, The Netherlands) [Schmoll H-J, Souchon R, Krege S et al. European consensus on diagnosis and treatment of germ-cell cancer: a report of the European Germ-Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004; 15: 1377-1399; Krege S, Beyer J, Souchon R et al. European consensus conference on diagnosis and treatment of germ-cell cancer: a report of the second meeting of the European Germ-Cell Cancer Consensus group (EGCCCG): part I. Eur Urol 2008; 53: 478-496; Krege S, Beyer J, Souchon R et al. European consensus conference on diagnosis and treatment of germ-cell cancer: a report of the second meeting of the European Germ-Cell Cancer Consensus group (EGCCCG): part II. Eur Urol 2008; 53: 497-513]. A panel of 56 of 60 invited GCC experts from all across Europe discussed all aspects on diagnosis and treatment of GCC, with a particular focus on acute and late toxic effects as well as on survivorship issues. The panel consisted of oncologists, urologic surgeons, radiooncologists, pathologists and basic scientists, who are all actively involved in care of GCC patients. Panelists were chosen based on the publication activity in recent years. Before the meeting, panelists were asked to review the literature published since 2006 in 20 major areas concerning all aspects of diagnosis, treatment and follow-up of GCC patients, and to prepare an updated version of the previous recommendations to be discussed at the conference. In addition, similar to 50 E-vote questions were drafted and presented at the conference to address the most controversial areas for a poll of expert opinions. Here, we present the main recommendations and controversies of this meeting. The votes of the panelists are added as online supplements.

AB - In November 2011, the Third European Consensus Conference on Diagnosis and Treatment of Germ-Cell Cancer (GCC) was held in Berlin, Germany. This third conference followed similar meetings in 2003 (Essen, Germany) and 2006 (Amsterdam, The Netherlands) [Schmoll H-J, Souchon R, Krege S et al. European consensus on diagnosis and treatment of germ-cell cancer: a report of the European Germ-Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004; 15: 1377-1399; Krege S, Beyer J, Souchon R et al. European consensus conference on diagnosis and treatment of germ-cell cancer: a report of the second meeting of the European Germ-Cell Cancer Consensus group (EGCCCG): part I. Eur Urol 2008; 53: 478-496; Krege S, Beyer J, Souchon R et al. European consensus conference on diagnosis and treatment of germ-cell cancer: a report of the second meeting of the European Germ-Cell Cancer Consensus group (EGCCCG): part II. Eur Urol 2008; 53: 497-513]. A panel of 56 of 60 invited GCC experts from all across Europe discussed all aspects on diagnosis and treatment of GCC, with a particular focus on acute and late toxic effects as well as on survivorship issues. The panel consisted of oncologists, urologic surgeons, radiooncologists, pathologists and basic scientists, who are all actively involved in care of GCC patients. Panelists were chosen based on the publication activity in recent years. Before the meeting, panelists were asked to review the literature published since 2006 in 20 major areas concerning all aspects of diagnosis, treatment and follow-up of GCC patients, and to prepare an updated version of the previous recommendations to be discussed at the conference. In addition, similar to 50 E-vote questions were drafted and presented at the conference to address the most controversial areas for a poll of expert opinions. Here, we present the main recommendations and controversies of this meeting. The votes of the panelists are added as online supplements.

KW - consensus conference

KW - diagnosis

KW - germ-cell cancer

KW - late toxic effects

KW - long-term follow-up

KW - treatment

U2 - 10.1093/annonc/mds579

DO - 10.1093/annonc/mds579

M3 - Review article

C2 - 23152360

SN - 1569-8041

VL - 24

SP - 878

EP - 888

JO - Annals of Oncology

JF - Annals of Oncology

IS - 4

ER -

Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

Sammanfattning

Ämnesklassifikation (UKÄ)

FN:s Globala mål

Tillgång till dokument

Fingeravtryck

Citera det här